Immune checkpoint inhibitor sintilimab-induced lethal myocarditis overlapping with myasthenia gravis in thymoma patient: A case report

Immune checkpoint inhibitors have been extensively used and significantly improved the clinical outcomes in multiple types of cancer. But the immune-related adverse events occur frequently, particularly in thymoma. The cardiac immune-related adverse, which is relatively rare but fatal, have been inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen, Zhong, Bingdi, He, Jing, Liao, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101245/
https://www.ncbi.nlm.nih.gov/pubmed/37058040
http://dx.doi.org/10.1097/MD.0000000000033550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101245/
https://www.ncbi.nlm.nih.gov/pubmed/37058040
http://dx.doi.org/10.1097/MD.0000000000033550

Ejemplares similares